Basal Anti Mullerian hormone levels and endometrial thickness at midcycle can predict the outcome after clomiphene citrate stimulation in anovulatory women with PCOS, a retrospective study

被引:13
|
作者
Gaba, Aulona [1 ]
Hoerath, Steffen [2 ]
Hager, Marlene [2 ]
Marculescu, Rodrig [3 ]
Ott, Johannes [2 ]
机构
[1] Med Univ Vienna, Dept Obstet & Gynecol, Clin Div Obstet & Maternal Fetal Med, Vienna, Austria
[2] Med Univ Vienna, Dept Obstet & Gynecol, Clin Div Gynecol Endocrinol & Reprod Med, Spitalgasse 23, A-1090 Vienna, Austria
[3] Med Univ Vienna, Dept Lab Med, Vienna, Austria
关键词
Ovarian stimulation; Polycystic ovary syndrome; Endometrium thickness at midcycle; Clomiphene; AMH; LH; FSH ratio; PCOS; Infertility; POLYCYSTIC-OVARY-SYNDROME; OVULATION INDUCTION; INFERTILITY; PREGNANCY; DIAGNOSIS; MANAGEMENT; ESTRADIOL; CONSENSUS; OBESITY; CYCLES;
D O I
10.1007/s00404-019-05359-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose Recent studies reported that in polycystic ovary syndrome (PCOS) patients, other stimulation agents are superior to the popular first-line regimen, clomiphene citrate (CC) for ovarian stimulation. Nonetheless, CC is still widely used since it is not clear which patients will not respond to it. Furthermore, the prognostic value of endometrium thickness at midcycle is controversial. We aimed to find factors predicting the response to CC and the prognostic value of endometrial thickness at midcycle. Methods We collected data retrospectively from 89 anovulatory PCOS patients who had the first stimulation with 50 mg CC. We analyzed the basal levels of AMH, testosterone, LH, LH:FSH ratio and the endometrial thickness at midcycle by univariate, followed by multivariate regression. The outcome measures were pregnancy, follicle maturation and endometrial thickness at midcycle. Results Stimulation with 50 mg CC resulted in follicle maturation in 50.6% of the women and in 27.0% pregnancies. In the univariate analysis, greater endometrial thickness, lower LH and AMH levels and a lower LH:FSH ratio were associated with pregnancy (p < 0.05). In the multivariate analysis, only endometrial thickness remained predictive (p = 0.045). The endometrial thickness cutoff level of >= 8 mm showed a sensitivity of 87.5% (96% CI 67.6-97.3) and a specificity of 66.7% (95% CI 43.0-85.4) for prediction of pregnancy. In the multivariate analysis AMH levels 5.4 (3.4; 7.0) (ng/mL) predicted pregnancy (beta = - 0.194 +/- 0.092; p = 0.034) Conclusion We suggest to refrain from CC as first-line regimen in patients with AMH > 7 ng/ml. Under CC treatment, the cutoff value of >= 8 mm endometrium thickness at midcycle is associated with a better outcome.
引用
收藏
页码:1751 / 1757
页数:7
相关论文
共 6 条
  • [1] Basal Anti Mullerian hormone levels and endometrial thickness at midcycle can predict the outcome after clomiphene citrate stimulation in anovulatory women with PCOS, a retrospective study
    Aulona Gaba
    Steffen Hörath
    Marlene Hager
    Rodrig Marculescu
    Johannes Ott
    Archives of Gynecology and Obstetrics, 2019, 300 : 1751 - 1757
  • [2] CAN ANTI MULLERIAN HORMONE LEVELS PREDICT RESPONSE TO OVULATION INDUCTION WITH CLOMIPHENE CITRATE
    Ilangovan, K.
    Croucher, C.
    Ding, C.
    Sherriff, E.
    FERTILITY AND STERILITY, 2011, 96 (03) : S252 - S252
  • [3] Anti-Mullerian hormone is correlated with cumulative live birth in minimal ovarian stimulation with clomiphene citrate: a retrospective cohort study
    Ezoe, Kenji
    Ni, Xiaowen
    Kobayashi, Tamotsu
    Kato, Keiichi
    BMC PREGNANCY AND CHILDBIRTH, 2020, 20 (01)
  • [4] Limited ability of circulating anti-Mullerian hormone to predict dominant follicular recruitment in PCOS women treated with clomiphene citrate: a comparison of two different assays
    Vaiarelli, Alberto
    Drakopoulos, Panagiotis
    Blockeel, Christophe
    De Vos, Michel
    van de Vijver, Arne
    Camus, Michel
    Cosyns, Stefan
    Tournaye, Herman
    Polyzos, Nikolaos P.
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 (03) : 227 - 230
  • [5] CAN ANTI-MULLERIAN HORMONE (AMH) LEVELS PREDICT RESPONSE TO OVULATION INDUCTION TREATMENTS IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME (PCOS)?
    Vagios, Stylianos
    Sacha, Caitlin R.
    Hsu, Jennifer Y.
    Dimitriadis, Irene
    Bormann, Charles L.
    James, Kaitlyn E.
    Souter, Irene
    FERTILITY AND STERILITY, 2019, 112 (03) : E391 - E392
  • [6] DO ANTI-MULLERIAN HORMONE (AMH) LEVELS PREDICT THE OPTIMAL CLOMIPHENE CITRATE (CC) DOSAGE IN POLYCYSTIC OVARIAN SYNDROME (PCOS) AND NON-PCOS PATIENTS UNDERGOING CC STIMULATED IUI (CC/IUI)?
    Mullin, C.
    Libby, V.
    Ulrich, A.
    Lesser, M.
    Hershlag, A.
    FERTILITY AND STERILITY, 2014, 102 (03) : E268 - E269